Aims And Background: Patients included in clinical trials are "selected", and they usually differ from those commonly treated.
Methods: From 1999 to 2004, in the Medical Oncology Department of Padua (Italy), 70 metastatic colorectal cancers were treated with FOLFOX4.
Results: Our results, compared with those of the registration trial (response rate, duration of response and progression-free survival) appeared lower; overall survival was improved.
Conclusions: The number of therapeutic regimens more than their type influenced the results.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/030089160609200301 | DOI Listing |
Publication Analysis
Top Keywords
folfox4 advanced
4
advanced colorectal
4
colorectal cancer
4
cancer monoinstitutional
4
monoinstitutional experience
4
experience aims
4
aims background
4
background patients
4
patients included
4
included clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!